Acomplia is the first of a newer class of prescription drugs that alters neural signals in the brain that influence appetite. Some research has shown that the drug can diminish activity in areas of the brain that are concerned with appetite. The early studies indicate that the drug is like a cannabinoid receptor blocker.
The drug has not been approved for use in the
Several studies have shown that acomplia can induce severe psychiatric problems including suicidal ideations, depression and anxiety. It is highly unlikely it will ever be permitted in the
No comments:
Post a Comment